GlobeImmune Inc. (NasdaqCM:GBIM) is exploring a potential sale. GlobeImmune officials said the company now has six full time employees down from 22 at the start of 2015 and is eyeing a sale of some or all of its assets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5 | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.31% | 21.83B | |
-10.58% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- GBIM Stock
- News GlobeImmune, Inc.
- GlobeImmune Weighing A Potential Sale